Krystal Biotech, Inc. KRYS Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s shares (basic)?
- Krystal Biotech, Inc. (KRYS) reported shares (basic) of 29.3M in Q1 2026.
- How has Krystal Biotech, Inc.'s shares (basic) changed year-over-year?
- Krystal Biotech, Inc.'s shares (basic) increased by 1.6% year-over-year, from 28.8M to 29.3M.
- What is the long-term trend for Krystal Biotech, Inc.'s shares (basic)?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s shares (basic) has grown at a 7.1% compound annual growth rate (CAGR), from 87.9M to 115.6M.
- What does shares (basic) mean?
- The average number of shares held by investors during the period.
- How do you interpret shares (basic)?
- An increase suggests share issuance or stock-based compensation, while a decrease typically indicates share buybacks.
- How does shares (basic) compare across companies?
- Standard metric for share count; used to normalize earnings across different reporting periods.